The complete Scientific Program can be downloaded here.
The Program at a Glance is available here.
The program of Industry sponsored Symposia can be downloaded here.
Please note that all documents are updated to June 1, 2019 and they may differ from the final versions.
The titles of the abstracts selected for oral presentation (from 001 to 135) are included in the program, already available in the section "Scientific info and Program". The titles of the abstracts selected for poster presentation (from 136 to 285) and publication can be downloaded here.
The 15-ICML Educational Book can be accessed here.
The number of abstracts received on March 15 was much higher than 2017 (about 90 submissions more!), therefore the selection of oral presentations was a challenge. In fact, with the help and collaboration of almost 80 international experts, only 10% of submitted abstracts could be selected either for a regular session or for a "Focus on..." session and only 20% for poster presentation.
General sessions are devoted to either specific subtypes of lymphoid neoplasia (e.g. extranodal lymphomas, follicular lymphomas, CLL, etc), or to the presentation of laboratory and clinical research data grouped around a biologic topic (for example, microenvironment, signalling pathway, surface antigens).
"Focus on..." sessions (parallel oral sessions highlighting abstracts of scientific value but not presented in general sessions) run in parallel and each one is focused on a particular topic. The one-hour sessions, consisting of six presentations of 10 minutes each, are devoted to:
- Mantle Cell lymphoma
- PET imaging
- Paediatric lymphoma
- Results from single agent trials
- Ongoing trials
- CLL and more
- Chemotherapy-free strategies
- Non-clinical and early clinical data with new combinations
- Non clinical new drugs
- High risk Large B-Cell lymphomas
- Indolent non-follicular lymphomas
Key Note Lectures:
- Henry Kaplan Memorial Lecture and San Salvatore Foundation Award
"Next generation CAR T Cells for lymphoma and beyond"
Carl H. June, Philadelphia, PA (USA)
- Gianni Bonadonna Memorial Lecture (supported by American Association for Cancer Research)
“Precision Epigenetic Therapy for B-cell lymphomas”
Ari M. Melnick, New York, NY (USA)
- John Ultmann Memorial Lecture (supported by European School of Oncology)
“Thirty years of T-cell lymphomas”
Philippe Gaulard, Créteil (France)
Educational symposia (parallel sessions):
a) "Treating Hodgkin Lymphoma in the new millennium"
Options for first line therapy: Peter W.M. Johnson, Southampton (UK)
Relapsed and refractory disease: Ann S. LaCasce, Boston, MA (USA)
Treatment of elderly patients: Andreas Engert, Cologne (Germany) - Chairman
b) “New drugs for NHL: beyond chemotherapy"
CAR T Cell therapy: full speed ahead: Renier J. Brentjens, New York, NY (USA)
New drugs for old targets: Gilles A. Salles, Lyon (France) - Chairman
New drugs for new targets: Anas Younes, New York, NY (USA)
Meet the Professor sessions:
1) Multiple myeloma: every year a new standard? - S. Vincent Rajkumar, Rochester, MN (USA)
2) How to approach CLL in clinical practice - Michael Hallek, Cologne (Germany)
3) Managing the toxicities of CAR T-cell therapy - Sattva S. Neelapu, Houston, TX (USA)
4) What we should know about NK/T-cell lymphomas – Weili Zhao, Shanghai (China)
5) Cutaneous lymphomas – Werner Kempf, Zurich (Switzerland)
6) PCNSL, a curable disease – Tracy T. Batchelor, Boston, MA (USA)
7) Breast implant associated ALCL and other rare T-cell lymphomas – Laurence de Leval, Lausanne (CH)
8) Liquid biopsy in NHL: a clinical tool, already? - Wyndham H. Wilson, Bethesda, MD (USA)
9) Double Hit lymphoma, so what? - Andrew Davies, Southampton (UK)
10) The modern approach to mantle cell lymphoma – Simon Rule, Plymouth (UK)
11) New treatment options in Hairy Cell Leukemia with focus on BRAF inhibitors - Brunangelo Falini, Perugia (Italy)
12) Rare B cell lymphomas in children and adolescents – Wilhelm Wössmann, Hamburg (Germany) and Leticia Quintanilla-Martinez de Fend, Tübingen (Germany)
Clinical discussion sessions have presenters of outstanding centers addressing cases which are not trivial nor very rare, but rather situations commonly encountered where the solution remains controversial. The format is a sort of Europe vs. USA debate: we had Lysa (France) vs Mayo Clinic in 2013, FIL (Italy) vs New York centers in 2015 and German vs Californian institutes in 2017.
This time the following Spanish and Texan experts will present cases and discuss the treatment options:
1) HL: Ana Maria Sureda Balari vs Hun Ju Lee
2) FL/Indolent Lymphoma: Mariano Provencio Pulla vs Loretta J. Nastoupil
3) PTCL: Alejandro Martín vs Nathan H. Fowler
4) DLBCL: Eva Giné Soca vs Jason R. Westin
5) CLL: Julio Delgado vs Philip A. Thompson
6) Difficult pathological cases: Armando Lopez-Guillermo vs Fredrick B. Hagemeister
7) Radiotherapy for lymphomas: Timothy Illidge (Manchester, UK) vs Bouthaina S. Dabaja
“Take home messages”
Jonathan W. Friedberg, Rochester, NY (USA)
Special AACR-ICML session
After the 2015 and 2017 positive and fruitful experiences, AACR and ICML will organize once again in 2019 a special joint session. The session will be devoted to the role of non-clinical models as bridges to early clinical trials.
Special sessions devoted to radiotherapy, organized in collaboration with ILROG (International Lymphoma Radiation Oncology Group): the following two satellite workshops open to all 15-ICML attendees will take place:
- Tuesday, June 18: "Lymphoma radiotherapy: new guidelines from ILROG", from 15 to 17:15 in University Aula Magna;
- Friday, June 21: "Radiotherapy in the elderly lymphoma patient" and "Dose fractionation issues in radiotherapy of lymphomas", from 9 to 12 in University Auditorium.
IBSA Foundation for Scientific Research - Special Forum
As in 2017, when the event "Basic mechanisms of cancer immunotherapy” took place, ICML participants will again have the possibility to join the IBSA Foundation Special Forum. The forum will be organised in the Lugano University Auditorium and the program will be defined in collaboration with the Foundation for the Institute of Oncology Research (IOR).
IV International Workshop on Canine Lymphoma
This well-attended meeting fosters interdisciplinary contacts between researchers studying lymphoma in canine and other species. The 2019 edition will comprise an invited plenary lecture on a cutting-edge topic, an update on the activities of the European Canine Lymphoma Network, a round table on state-of-the-art on canine multicentric lymphoma staging, and, for the first time, a session with free oral research presentations.